HomeENTO • NASDAQ
add
Entero Therapeutics Inc
Previous close
$4.96
Day range
$4.25 - $5.20
Year range
$0.97 - $5.84
Market cap
8.74M USD
Avg Volume
323.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 638.86K | -81.35% |
Net income | -998.27K | 88.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -635.22K | 81.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.47K | -99.32% |
Total assets | 85.06M | -1.42% |
Total liabilities | 29.68M | 91.63% |
Total equity | 55.38M | — |
Shares outstanding | 1.59M | — |
Price to book | -1.25 | — |
Return on assets | -1.88% | — |
Return on capital | -2.81% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -998.27K | 88.67% |
Cash from operations | -54.88K | 98.41% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -54.88K | 98.02% |
Free cash flow | 603.73K | 100.84% |
About
Founded
2014
Headquarters
Website
Employees
2
